Thailand is rapidly emerging as the premier hub for clinical research in Southeast Asia. With the Thailand Medical Hub Policy, the government has prioritized digital healthcare transformation. Remote Patient Monitoring (RPM) is no longer a luxury but a necessity for clinical trials involving Thailand's aging population and diverse geography. By integrating advanced sensors and 4G/5G DTU communication, manufacturers are overcoming the "last mile" hurdle in patient data collection from remote provinces to Bangkok's central research facilities.
Worldwide, the shift toward Decentralized Clinical Trials (DCTs) has accelerated by 400% since 2020. Global CROs (Contract Research Organizations) are demanding unified platforms that combine hardware—like serial communication DTUs and IoT gateways—with cloud-based analytics. Dongguan Trial Medical Co., Ltd. sits at the intersection of this demand, exporting high-precision monitoring hardware that meets stringent FDA and Thailand MOPH (Ministry of Public Health) standards.
Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations, pharmaceutical companies, healthcare institutions, and academic research centers worldwide.
Future monitoring units in Thailand will transition from simple data passthrough to edge-processing devices. Our Remote Data Acquisition Units are already integrating local filtering to reduce bandwidth costs on Thai 5G networks, ensuring only relevant clinical anomalies are transmitted to the cloud.
Leveraging AI to predict Adverse Events (AEs) before they occur. By monitoring vital signs through autonomous UGV surveillance or wearable sensors, researchers can intervene 24-48 hours earlier than traditional methods.
Compliance with Thailand's Personal Data Protection Act (PDPA) is critical. Our technology roadmap includes end-to-end encryption and blockchain-based audit trails to ensure patient data integrity and trial reliability.
Trial Medical's product portfolio includes remote clinical trial monitoring devices, wearable health data collection systems, patient engagement platforms, electronic clinical outcome assessment solutions, digital research tools, remote safety monitoring systems, and decentralized trial support technologies. These solutions are designed to facilitate real-time data collection, improve participant engagement, streamline study management, and enhance operational efficiency throughout the clinical research process.
Supported by an experienced team of engineers, software developers, and quality management professionals, Trial Medical continuously invests in research and development to address the evolving needs of modern clinical studies. The company integrates advanced connectivity technologies, cloud-based data management capabilities, and intelligent monitoring functions to support reliable and scalable clinical research operations.
Trial Medical
